| Company News |
Pharmaxis Announces Agreement for European Marketing of Bronchitol Pharmaxis
(August 31, 2010)
|
Quarterly Report to Shareholders June 2010 Pharmaxis
(July 21, 2010)
|
EventAnalyzer: Weekly Market Movers (to 25 Jun 2010)
(June 28, 2010)
|
Investor Conference Call - Clinical Trial Results Pharmaxis
(June 22, 2010)
|
Pharmaxis Announces Results for Second Phase III Trial of Bronchitol in Cystic Fibrosis Pharmaxis
(June 22, 2010)
|
Pharmaxis Announces Sustained Benefit in Cystic Fibrosis Following Long Term Bronchitol Treatment Pharmaxis
(May 17, 2010)
|
Pharmaxis Provides FDA Resubmission for Aridol U.S.Marketing Application Pharmaxis
(April 27, 2010)
|
Quarterly Report to Shareholders March 2010 Pharmaxis
(April 14, 2010)
|
Conference Call Details - Quarterly Report to Shareholders and Investor Conference Call Pharmaxis
(April 12, 2010)
|
Pharmaxis Completes Phase II Clinical Study With ASM8 in Asthma Patients Pharmaxis
(March 11, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.
|
| Company Profile |
|
|
| Profile
|
Pharmaxis, an Australian pharmaceutical company focused on development of therapeutic products for the treatment of chronic respiratory and autoimmune diseases. |
| Listed or Private Company
|
Listed |
| Company Classification
|
Biotechnology |
| Company Website
|
Website
|
|
Full Company Profile Information
| EventAnalyzer - Last Key Event |
|
| Closing Price DateClosing Price Date
|
EventAnalyzer Note
|
Market Cap (US $m)
|
Change (%)
|
Change (+$m)
|
| 12/2/2009 |
1 Dec: Company announces headline results for its phase III trial of Bronchitol in patients with cystic fibrosis, in which the drug shows a significant improvement in lung function. |
521 |
10.8% |
51 |
|
| Top 3 Products (Worldwide Sales 2007/08) |
|
|
| Therapy Area Focus in 2008 |
| Pharmaxis
|
|
2008 |
| WW Rx & OTC Sales By Therapy Area
|
| Main Categories
|
| Respiratory |
0 |
| Other Rx & OTC Pharma |
0 |
|
| EvaluatePharma® Coverage of Marketed and Pipeline Products |
|
|
|
Register to access more FREE content:
- 2009 Product Sales analysis
- 2009 Pharmaceutical Sales
- 2009 Market Share & Global Ranking
- Download to Excel
- Search 2 yrs of company press releases
|
|
|
|